The aim of this study was to investigate if brain atrophy in multiple sclerosis (MS) patients during the disease onset predicts long term disability. METHODS: MS patients with follow-up time of at least 7 years from disease onset and with baseline and second magnetic resonance 12 months later were included to measure brain atrophy. Expanded Disability Status Scale (EDSS) was categorized in three groups, EDSS=0, EDSS=1 and 2.5 and EDSS>2.5, and used as disability measure. RESULTS: Twenty-six patients were included. Mean atrophy during the first year in patients that reached an EDSS≥3 was -0.76±0.45 %, in patients with an EDSS between 1 and 2.5 was -0.59±0.56, while in patients with an EDSS of 0 it was -0.38±0.42 (p=0.003). DISCUSSION: Brain ...
The ability to reliably monitor disease progression in patients with multiple sclerosis (MS) is inte...
: We conducted a retrospective analysis on multiple sclerosis (MS) patients with perceived cognitive...
BACKGROUND: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Objective To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinical ...
BACKGROUND: Conventional MRI lesion measures modestly predict long term disability in some clinicall...
As atrophy represents the most relevant driver of progression in multiple sclerosis (MS), we investi...
Objective: To determine 30-year brain atrophy rates following clinically isolated syndromes and the ...
Background and purpose: To predict disability and cognition in multiple sclerosis (MS) after 6 and 1...
Objective: Magnetic resonance imaging (MRI) and clinical parameters are associated with disease prog...
Objective: To investigate the relationship between brain volume and disability worsening over ≥3 yea...
INTRODUCTION: Multiple sclerosis (MS) is characterized, besides focal lesions, by brain atrophy. Th...
Objective To evaluate the extent to which treatment effect on brain atrophy is able to mediate, at t...
BACKGROUND: Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous sys...
ObjectiveTo investigate the relationship between brain volume and disability worsening over ≥3 ...
Objective: To examine the predictive value of central atrophy in early multiple sclerosis (MS) patie...
The ability to reliably monitor disease progression in patients with multiple sclerosis (MS) is inte...
: We conducted a retrospective analysis on multiple sclerosis (MS) patients with perceived cognitive...
BACKGROUND: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...
Objective To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinical ...
BACKGROUND: Conventional MRI lesion measures modestly predict long term disability in some clinicall...
As atrophy represents the most relevant driver of progression in multiple sclerosis (MS), we investi...
Objective: To determine 30-year brain atrophy rates following clinically isolated syndromes and the ...
Background and purpose: To predict disability and cognition in multiple sclerosis (MS) after 6 and 1...
Objective: Magnetic resonance imaging (MRI) and clinical parameters are associated with disease prog...
Objective: To investigate the relationship between brain volume and disability worsening over ≥3 yea...
INTRODUCTION: Multiple sclerosis (MS) is characterized, besides focal lesions, by brain atrophy. Th...
Objective To evaluate the extent to which treatment effect on brain atrophy is able to mediate, at t...
BACKGROUND: Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous sys...
ObjectiveTo investigate the relationship between brain volume and disability worsening over ≥3 ...
Objective: To examine the predictive value of central atrophy in early multiple sclerosis (MS) patie...
The ability to reliably monitor disease progression in patients with multiple sclerosis (MS) is inte...
: We conducted a retrospective analysis on multiple sclerosis (MS) patients with perceived cognitive...
BACKGROUND: To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load a...